US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology market research reports and industry analysis

1    3    5  6  7  8  9  10  
Biologicals in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 137 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 547 drug targets that are included ...  |  read more...
USD 11,025
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... drugs known to affect more than 157 specific intracellular signaling pathways for the treatment of more than 25 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding ...  |  read more...
USD 2,246
Biologicals in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... developing 1686 biological drugs in 3815 developmental projects in cancer. In addition, there are 28 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 932 drugs. Biologicals In ...  |  read more...
USD 11,246
3-D Matrix, Ltd. (7777) - Financial and Strategic SWOT Analysis Review
7/15/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
FK-Biotecnologia SA - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... glassware, chemical reagents, and solutions and for the diagnostic of HCG, HIV, dengue and cancer. FK-Biotec develops anti-cancer cellular vaccine technology, used in monoclonal antibodies for therapeutic and diagnostic. The company provides services such as ...  |  read more...
USD 750
PrognosDx Health, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... treatment of prostate cancer and bladder cancer. The company’s rxscore is a therapeutic test for pancreatic, breast, colorectal, and lung cancers. The company conducts clinical validation studies at medical centers throughout the US. PrognosDx is ...  |  read more...
USD 750
Biomedal S.L. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... Biomedal Diagnostics. Biomedal through its biomedal life science division develops and commercializes products and services for life sciences research, and technology for industrial bioprocesses. The company’s biomedal life science division offers customized research services to ...  |  read more...
USD 750
Pantec Biosolutions AG - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... medical solutions and (P.L.E.A.S.E.) painless laser epidermal system devices. Pantec provides needless therapy by a convenient intraepidermal method and also develops its P.L.E.A.S.E. platform for active intraepider delivery of biopharmaceuticals such as hormones, proteins, peptides ...  |  read more...
USD 750
Protagen AG - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... lupus erythematosus, ankylosing spondylitis, systemic sclerosis, multiple sclerosis and neuromyelitis optical. Protagen’s serotag biomarker development engine delivers biomarker signatures. The company also provides support services throughout the diagnostic test development and implementation process, and provides ...  |  read more...
USD 750
Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... chemical found throughout the body. HA enhances joint function and coats, protects, cushions and lubricates soft tissues. Priority markets include the US, Europe, the Middle East, Latin America, Asia and Turkey. Its research and manufacturing ...  |  read more...
USD 750
Histogenics Corporation - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... product offers an alternative for treating discrete cartilage defects. Histogenics also develops products used in sports injuries and joint replacements. The company offers products for the treatment of active patients suffering from articular cartilage derived ...  |  read more...
USD 750
Hybrigenics S.A. (ALHYG) - Financial and Strategic SWOT Analysis Review
7/15/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
OPERON S.A - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... CD2WB, chagas WB, lisaKIT PSA, lisaKIT AFP, lisaKIT toxo IgG, HLA B5701 strip, HPV – low risk, HPV – high+low risk, hemochromastrip and others. Operon offers services, such as manufacturing in OEM format, and lateral ...  |  read more...
USD 750
KineMed, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... chemical pathways within living systems. KineMed concentrates in the therapeutic areas of muscle metabolism, proteome metabolism, inflammation, immunity, neurobiology, plasma lipids and lipoproteins, pancreatic islet cell proliferation and lipid synthesis. Its product pipeline includes KM-011 ...  |  read more...
USD 750
Celera Group : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Celera Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Charles River Laboratories International, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Charles River Laboratories International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...  |  read more...
USD 350
Genetic Technologies Limited : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Genetic Technologies Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Lonza Group, Ltd. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Lonza Group, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
TiGenix N.V. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' TiGenix N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
International Stem Cell Corporation : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' International Stem Cell Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
USD 350
Immunocellular Therapeutics, Ltd. (formerly Optical Molecular Imaging, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Immunocellular Therapeutics, Ltd. (formerly Optical Molecular Imaging, Inc.) Mergers & Acquisitions (M&A), Partnerships ...  |  read more...
USD 350
Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) Mergers & Acquisitions (M&A), Partnerships ...  |  read more...
USD 350
BG Medicine, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' BG Medicine, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Novartis AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Novartis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Champions Oncology, Inc. (formerly Champions Biotechnology, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Champions Oncology, Inc. (formerly Champions Biotechnology, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances ...  |  read more...
USD 350
1    3    5  6  7  8  9  10